Entries by Emily Masline


DIR Fees: What NCPA Wants from Part D

Published by Drug Topics: Direct and indirect remuneration fees have been one of the most contentious issues between retail pharmacists and PBMs and payers, which charge the “clawback” fees months after prescriptions are filled. NCPA members have said DIR fees are the top issue they would like to see resolved in 2017. “While the proposed […]